Reclassification of CLSI criteria for ciprofloxacin and levofloxacin susceptibility against Pseudomonas aeruginosa: Implications for patients with cystic fibrosis (CF).
Beverley Cherie MillarCamila M MalnarcicJohn McCaughanJohn Edmund MoorePublished in: The clinical respiratory journal (2019)